
DSGN
USDDesign Therapeutics Inc. Common Stock
$6.240-0.130 (-2.041%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$6.370
High
$6.635
Low
$6.160
Volume
0.13M
Company Fundamentals
Market Cap
355.4M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.18M
Exchange
NMS
Currency
USD
52-Week Range
Low $2.6Current $6.240High $7.77
Related News
GlobeNewswire
Design Therapeutics Appoints Justin Gover to Board of Directors
CARLSBAD, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (NASDAQ:DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced the
View more
Related Stocks
MBNKP
Medallion Bank Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock Series F
NASDAQ
Commercial Bank...
DFLIW
Dragonfly Energy Holdings Corp. Warrant
NASDAQ
Industrial Mach...
LC
LendingClub Corporation
NASDAQ
Finance: Consum...
TPL
Texas Pacific Land Corporation
NASDAQ
Oil & Gas Produ...
CYCCP
Cyclacel Pharmaceuticals Inc. 6% Convertible Preferred Stock
NASDAQ
Biotechnology: ...
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.